The study reported a high number of PRIMPOL-deficient tumors in breast cancer patients diagnosed with invasive lobular and ductal carcinoma, and the PRIMPOL−/− tumors were found to exhibit a mutation load that was nearly twice as high as in PRIMPOL-proficient tumors. Here, PRIMPOL is linked to breast cancer.